ABO and COVID-19: ABO(H) glycans on the viral S protein or lung epithelial cells may impact viral infection [32], while ABO(H) antigens on von Willebrand factor (vWF) and coagulation factor VIII (FVIII) are known to impact thromboembolic risk, which may impact COVID-19 disease severity [32,33].